Pharmacologic management of aggression in the elderly.
Issues related to the epidemiology, nosology, and differential diagnosis of organic aggressive disorders in the elderly are discussed. Rating and monitoring of aggressive events using the Overt Aggression Scale are reviewed. The management of acute aggression with antipsychotic agents and benzodiazepines is presented, as well as an approach for using beta-blockers, anticonvulsant agents, and serotonin-specific antidepressants and an antianxiety agent for the treatment of chronic aggression.
Yudofsky
S C
SC
Department of Psychiatry, University of Chicago School of Medicine, Ill.
Silver
J M
JM
Hales
R E
RE
D000368:Aged; D000374:Aggression / Q000187:drug effects*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D002065:Buspirone / Q000627:therapeutic use; D003704:Dementia / Q000188:drug therapy / Q000523:psychology; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use; D019965:Neurocognitive Disorders / Q000188:drug therapy* / Q000523:psychology
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D006220:Haloperidol; D008140:Lorazepam; D002065:Buspirone